Chemical hemorrhagic cystitis: Diagnostic and therapeutic pitfalls (Review)

Exp Ther Med. 2021 Jun;21(6):624. doi: 10.3892/etm.2021.10056. Epub 2021 Apr 14.

Abstract

Chemical cystitis (CC) is an inflammation of the bladder caused by various chemical agents ingested intentionally or accidentally. It is linked to chemotherapeutic agents such as cyclophosphamide, therapeutic agents for diverse diseases, and anesthetic agents consumed abusively for recreational effects such as ketamine, or can be linked to environmental and surrounding factors such as soaps, gels, spermicides, and dyes. CC is a pathology with an increasing incidence that is inadequately treated due to its infectious cystitis-like symptoms. The hemorrhagic form can have a rampant evolution. Treatment options of CC and its complications are under continuous research with no accepted standardized sequence. In many situations, the treatments are difficult to obtain, administer, and follow-up. In addition, the lack of experience of the physician may pose other obstacles in delivering treatment to the patient. In conclusion, CC is a disease with an increasing incidence, challenging to diagnose, which is frequently mistreated, and has multiple treatment modalities that still require standardization in administration and sequencing.

Keywords: chemical cystitis; hematuria; hemorrhagic cystitis; intravesical therapy; noninfectious cystitis; urinary bladder inflammation.

Publication types

  • Review

Grants and funding

Funding: No funding was received.